content

GSK and CureVac to develop next generation mRNA COVID-19 vaccines

GlaxoSmithKline plc and CureVac N.V. announced a new โ‚ฌ150m collaboration, building on their existing relationship, to jointly develop next generation mRNA vaccines for COVID-19...

Oxford leads first trial investigating dosing with alternating vaccines

The University of Oxford is to lead the first trial to explore alternating different COVID-19 vaccines, to explore the potential for flexibility in delivery...

Metrics Contract Services Appoints New VP of Business Development

Metrics Contract Services, a full-service contract development and manufacturing organization (CDMO) in novel oral solid dose products, has appointed Britton Jimenez as Vice President...

Abzena selected to develop and manufacture antibody cocktail for Immunome’s COVID-19 Antibody Based Treatment

Immunome, Inc., a biopharmaceutical company utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics, and Abzena, a partner...

WuXi STA to Purchase Bristol Myers Squibb Manufacturing Facility in Couvet, Switzerland

Bristol Myers Squibb and WuXi STA โ€“ a subsidiary of WuXi AppTec โ€“ announced that WuXi STA has agreed to purchase Bristol Myers Squibbโ€™s...

Syntegon validates first AI-equipped visual inspection system in production line

Syntegon Technology recently installed the first fully validated visual inspection system utilizing Artificial Intelligence (AI) in an automated inspection machine. The installation constitutes a...

eClinical Solutions Launches elluminate Clinical Trial Management System for Faster Drug Development

eClinical Solutions LLC, a global provider of cloud-based enterprise software and software-driven clinical data services, announced the launch of the elluminateยฎ Clinical Trial Management...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read